Project
Illumina Body Map 2
Navigation
Downloads
Results for CDC5L
Z-value: 1.80
Motif logo
Transcription factors associated with CDC5L
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
CDC5L
|
ENSG00000096401.7 | cell division cycle 5 like |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| CDC5L | hg19_v2_chr6_+_44355257_44355315 | 0.29 | 1.1e-01 | Click! |
Activity profile of CDC5L motif
Sorted Z-values of CDC5L motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr18_+_616711 | 8.34 |
ENST00000579494.1
|
CLUL1
|
clusterin-like 1 (retinal) |
| chr18_+_616672 | 7.97 |
ENST00000338387.7
|
CLUL1
|
clusterin-like 1 (retinal) |
| chr10_-_69597915 | 6.20 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr3_+_178276488 | 5.81 |
ENST00000432997.1
ENST00000455865.1 |
KCNMB2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
| chr10_-_69597810 | 5.79 |
ENST00000483798.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr7_-_16921601 | 5.11 |
ENST00000402239.3
ENST00000310398.2 ENST00000414935.1 |
AGR3
|
anterior gradient 3 |
| chr8_-_124749609 | 5.06 |
ENST00000262219.6
ENST00000419625.1 |
ANXA13
|
annexin A13 |
| chr9_-_28670283 | 4.79 |
ENST00000379992.2
|
LINGO2
|
leucine rich repeat and Ig domain containing 2 |
| chr10_-_69597828 | 4.13 |
ENST00000339758.7
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr16_+_80574854 | 3.67 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
| chr18_-_25616519 | 3.55 |
ENST00000399380.3
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
| chrX_+_36246735 | 3.52 |
ENST00000378653.3
|
CXorf30
|
chromosome X open reading frame 30 |
| chr1_+_43613612 | 3.22 |
ENST00000335282.4
|
FAM183A
|
family with sequence similarity 183, member A |
| chr6_-_165723088 | 3.18 |
ENST00000230301.8
|
C6orf118
|
chromosome 6 open reading frame 118 |
| chr5_-_35938674 | 3.15 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
| chr3_-_155394099 | 3.03 |
ENST00000414191.1
|
PLCH1
|
phospholipase C, eta 1 |
| chr5_+_94727048 | 2.88 |
ENST00000283357.5
|
FAM81B
|
family with sequence similarity 81, member B |
| chr2_+_166095898 | 2.85 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr15_+_81391740 | 2.81 |
ENST00000561216.1
|
C15orf26
|
chromosome 15 open reading frame 26 |
| chr18_-_24445729 | 2.77 |
ENST00000383168.4
|
AQP4
|
aquaporin 4 |
| chr11_-_13517565 | 2.68 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
| chr8_+_24772455 | 2.63 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
| chr17_+_45908974 | 2.62 |
ENST00000269025.4
|
LRRC46
|
leucine rich repeat containing 46 |
| chr11_-_31014214 | 2.58 |
ENST00000406071.2
ENST00000339794.5 |
DCDC1
|
doublecortin domain containing 1 |
| chr11_-_83984231 | 2.50 |
ENST00000330014.6
ENST00000537455.1 ENST00000376106.3 ENST00000418306.2 ENST00000531015.1 |
DLG2
|
discs, large homolog 2 (Drosophila) |
| chr10_-_61495760 | 2.49 |
ENST00000395347.1
|
SLC16A9
|
solute carrier family 16, member 9 |
| chr19_-_10697895 | 2.46 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr16_+_4845379 | 2.39 |
ENST00000588606.1
ENST00000586005.1 |
SMIM22
|
small integral membrane protein 22 |
| chr15_+_54901540 | 2.34 |
ENST00000539562.2
|
UNC13C
|
unc-13 homolog C (C. elegans) |
| chr4_-_168155577 | 2.34 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr1_-_204135450 | 2.31 |
ENST00000272190.8
ENST00000367195.2 |
REN
|
renin |
| chrX_+_36254051 | 2.25 |
ENST00000378657.4
|
CXorf30
|
chromosome X open reading frame 30 |
| chrX_+_103031758 | 2.24 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
| chr3_+_35721106 | 2.23 |
ENST00000474696.1
ENST00000412048.1 ENST00000396482.2 ENST00000432682.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr15_+_32933866 | 2.20 |
ENST00000300175.4
ENST00000413748.2 ENST00000494364.1 ENST00000497208.1 |
SCG5
|
secretogranin V (7B2 protein) |
| chr8_-_133637624 | 2.16 |
ENST00000522789.1
|
LRRC6
|
leucine rich repeat containing 6 |
| chr9_-_93405352 | 2.15 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr12_-_87232644 | 2.12 |
ENST00000549405.2
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
| chr6_-_136847099 | 2.10 |
ENST00000438100.2
|
MAP7
|
microtubule-associated protein 7 |
| chr12_+_79439405 | 2.08 |
ENST00000552744.1
|
SYT1
|
synaptotagmin I |
| chr8_+_35649365 | 2.06 |
ENST00000437887.1
|
AC012215.1
|
Uncharacterized protein |
| chr3_-_155394152 | 2.06 |
ENST00000494598.1
|
PLCH1
|
phospholipase C, eta 1 |
| chr6_+_80129989 | 2.05 |
ENST00000429444.1
|
RP1-232L24.3
|
RP1-232L24.3 |
| chr6_-_136847610 | 2.04 |
ENST00000454590.1
ENST00000432797.2 |
MAP7
|
microtubule-associated protein 7 |
| chr1_+_38022572 | 2.04 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr3_+_35721182 | 2.04 |
ENST00000413378.1
ENST00000417925.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr12_-_21487829 | 2.03 |
ENST00000445053.1
ENST00000452078.1 ENST00000458504.1 ENST00000422327.1 ENST00000421294.1 |
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2 |
| chr1_-_154178803 | 2.00 |
ENST00000368525.3
|
C1orf189
|
chromosome 1 open reading frame 189 |
| chr6_-_49681235 | 1.99 |
ENST00000339139.4
|
CRISP2
|
cysteine-rich secretory protein 2 |
| chr1_+_15668240 | 1.97 |
ENST00000444385.1
|
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
| chr3_+_63428982 | 1.93 |
ENST00000479198.1
ENST00000460711.1 ENST00000465156.1 |
SYNPR
|
synaptoporin |
| chr1_+_38022513 | 1.92 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr18_-_31628558 | 1.83 |
ENST00000535384.1
|
NOL4
|
nucleolar protein 4 |
| chr15_+_54305101 | 1.83 |
ENST00000260323.11
ENST00000545554.1 ENST00000537900.1 |
UNC13C
|
unc-13 homolog C (C. elegans) |
| chr3_-_120365866 | 1.78 |
ENST00000475447.2
|
HGD
|
homogentisate 1,2-dioxygenase |
| chr8_+_76452097 | 1.77 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
| chr13_+_78315295 | 1.75 |
ENST00000351546.3
|
SLAIN1
|
SLAIN motif family, member 1 |
| chr13_+_78315348 | 1.74 |
ENST00000441784.1
|
SLAIN1
|
SLAIN motif family, member 1 |
| chrX_+_35937843 | 1.71 |
ENST00000297866.5
|
CXorf22
|
chromosome X open reading frame 22 |
| chr3_+_107096188 | 1.71 |
ENST00000261058.1
|
CCDC54
|
coiled-coil domain containing 54 |
| chr6_+_76599809 | 1.70 |
ENST00000430435.1
|
MYO6
|
myosin VI |
| chr15_-_94614049 | 1.69 |
ENST00000556447.1
ENST00000555772.1 |
CTD-3049M7.1
|
CTD-3049M7.1 |
| chr12_-_371994 | 1.68 |
ENST00000343164.4
ENST00000436453.1 ENST00000445055.2 ENST00000546319.1 |
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13 |
| chr18_-_40857493 | 1.68 |
ENST00000255224.3
|
SYT4
|
synaptotagmin IV |
| chr3_+_108321623 | 1.61 |
ENST00000497905.1
ENST00000463306.1 |
DZIP3
|
DAZ interacting zinc finger protein 3 |
| chr5_-_61031495 | 1.61 |
ENST00000506550.1
ENST00000512882.2 |
CTD-2170G1.2
|
CTD-2170G1.2 |
| chr5_+_173473662 | 1.61 |
ENST00000519717.1
|
NSG2
|
Neuron-specific protein family member 2 |
| chr6_+_127898312 | 1.61 |
ENST00000329722.7
|
C6orf58
|
chromosome 6 open reading frame 58 |
| chr7_-_14880892 | 1.61 |
ENST00000406247.3
ENST00000399322.3 ENST00000258767.5 |
DGKB
|
diacylglycerol kinase, beta 90kDa |
| chr12_-_45307711 | 1.60 |
ENST00000333837.4
ENST00000551949.1 |
NELL2
|
NEL-like 2 (chicken) |
| chr1_+_197237352 | 1.57 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
| chr17_-_7493390 | 1.56 |
ENST00000538513.2
ENST00000570788.1 ENST00000250055.2 |
SOX15
|
SRY (sex determining region Y)-box 15 |
| chrX_+_107020963 | 1.56 |
ENST00000509000.2
|
NCBP2L
|
nuclear cap binding protein subunit 2-like |
| chr2_-_100925967 | 1.55 |
ENST00000409647.1
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr10_-_98118724 | 1.55 |
ENST00000393870.2
|
OPALIN
|
oligodendrocytic myelin paranodal and inner loop protein |
| chr18_+_50278430 | 1.54 |
ENST00000578080.1
ENST00000582875.1 ENST00000412726.1 |
DCC
|
deleted in colorectal carcinoma |
| chr10_-_81742364 | 1.54 |
ENST00000444384.3
|
SFTPD
|
surfactant protein D |
| chr14_+_62462541 | 1.53 |
ENST00000430451.2
|
SYT16
|
synaptotagmin XVI |
| chr3_+_35721130 | 1.52 |
ENST00000432450.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr10_-_23528745 | 1.52 |
ENST00000376501.5
|
C10orf115
|
chromosome 10 open reading frame 115 |
| chr12_+_79439461 | 1.51 |
ENST00000552624.1
|
SYT1
|
synaptotagmin I |
| chr19_+_16830815 | 1.50 |
ENST00000549814.1
|
NWD1
|
NACHT and WD repeat domain containing 1 |
| chr12_-_39734783 | 1.49 |
ENST00000552961.1
|
KIF21A
|
kinesin family member 21A |
| chr17_-_57604200 | 1.48 |
ENST00000577478.1
|
RP11-567L7.6
|
RP11-567L7.6 |
| chr18_-_24765248 | 1.48 |
ENST00000580774.1
ENST00000284224.8 |
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
| chr10_+_115511213 | 1.44 |
ENST00000361048.1
|
PLEKHS1
|
pleckstrin homology domain containing, family S member 1 |
| chr21_+_34442439 | 1.44 |
ENST00000382348.1
ENST00000333063.5 |
OLIG1
|
oligodendrocyte transcription factor 1 |
| chr15_+_81299370 | 1.44 |
ENST00000560091.1
|
C15orf26
|
chromosome 15 open reading frame 26 |
| chrX_+_36065053 | 1.43 |
ENST00000313548.4
|
CHDC2
|
calponin homology domain containing 2 |
| chr7_-_122339162 | 1.43 |
ENST00000340112.2
|
RNF133
|
ring finger protein 133 |
| chr5_+_147648393 | 1.43 |
ENST00000511106.1
ENST00000398450.4 |
SPINK13
|
serine peptidase inhibitor, Kazal type 13 (putative) |
| chr10_+_115511434 | 1.42 |
ENST00000369312.4
|
PLEKHS1
|
pleckstrin homology domain containing, family S member 1 |
| chr3_-_116163830 | 1.42 |
ENST00000333617.4
|
LSAMP
|
limbic system-associated membrane protein |
| chr9_-_19786926 | 1.42 |
ENST00000341998.2
ENST00000286344.3 |
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
| chr2_+_210444748 | 1.42 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
| chr1_-_86043921 | 1.41 |
ENST00000535924.2
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr2_+_210517895 | 1.41 |
ENST00000447185.1
|
MAP2
|
microtubule-associated protein 2 |
| chr3_+_63428752 | 1.38 |
ENST00000295894.5
|
SYNPR
|
synaptoporin |
| chr11_-_102651343 | 1.37 |
ENST00000279441.4
ENST00000539681.1 |
MMP10
|
matrix metallopeptidase 10 (stromelysin 2) |
| chr10_+_46994087 | 1.37 |
ENST00000374317.1
|
GPRIN2
|
G protein regulated inducer of neurite outgrowth 2 |
| chr2_-_100939195 | 1.37 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr9_-_21368075 | 1.36 |
ENST00000449498.1
|
IFNA13
|
interferon, alpha 13 |
| chr18_-_10701979 | 1.35 |
ENST00000538948.1
ENST00000285141.4 |
PIEZO2
|
piezo-type mechanosensitive ion channel component 2 |
| chr2_-_175712479 | 1.34 |
ENST00000443238.1
|
CHN1
|
chimerin 1 |
| chr17_+_48911942 | 1.34 |
ENST00000426127.1
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
| chr7_+_29519486 | 1.31 |
ENST00000409041.4
|
CHN2
|
chimerin 2 |
| chr2_-_44550441 | 1.31 |
ENST00000420756.1
ENST00000444696.1 |
PREPL
|
prolyl endopeptidase-like |
| chr2_+_200472779 | 1.31 |
ENST00000427045.1
ENST00000419243.1 |
AC093590.1
|
AC093590.1 |
| chr5_+_161495038 | 1.28 |
ENST00000393933.4
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
| chr16_+_33204156 | 1.28 |
ENST00000398667.4
|
TP53TG3C
|
TP53 target 3C |
| chr13_+_78315528 | 1.27 |
ENST00000496045.1
|
SLAIN1
|
SLAIN motif family, member 1 |
| chr6_-_49712072 | 1.26 |
ENST00000423399.2
|
CRISP3
|
cysteine-rich secretory protein 3 |
| chr18_-_31603603 | 1.26 |
ENST00000586553.1
|
NOL4
|
nucleolar protein 4 |
| chr16_-_5116025 | 1.26 |
ENST00000472572.3
ENST00000315997.5 ENST00000422873.1 ENST00000350219.4 |
C16orf89
|
chromosome 16 open reading frame 89 |
| chr13_-_86373536 | 1.25 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
| chr17_+_61151306 | 1.24 |
ENST00000580068.1
ENST00000580466.1 |
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
| chr12_+_81664424 | 1.23 |
ENST00000549161.1
ENST00000550138.1 |
RP11-121G22.3
|
RP11-121G22.3 |
| chr1_+_10509971 | 1.23 |
ENST00000320498.4
|
CORT
|
cortistatin |
| chrX_-_142605301 | 1.21 |
ENST00000370503.2
|
SPANXN3
|
SPANX family, member N3 |
| chr12_+_8309630 | 1.20 |
ENST00000396570.3
|
ZNF705A
|
zinc finger protein 705A |
| chr1_+_50513686 | 1.20 |
ENST00000448907.2
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr1_+_110254850 | 1.18 |
ENST00000369812.5
ENST00000256593.3 ENST00000369813.1 |
GSTM5
|
glutathione S-transferase mu 5 |
| chr8_+_104892639 | 1.18 |
ENST00000436393.2
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
| chr17_+_56315787 | 1.17 |
ENST00000262290.4
ENST00000421678.2 |
LPO
|
lactoperoxidase |
| chr14_-_80678512 | 1.17 |
ENST00000553968.1
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr8_-_57233103 | 1.17 |
ENST00000303749.3
ENST00000522671.1 |
SDR16C5
|
short chain dehydrogenase/reductase family 16C, member 5 |
| chr2_-_2334888 | 1.17 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
| chr5_+_140227048 | 1.17 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
| chr5_-_82969405 | 1.16 |
ENST00000510978.1
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1 |
| chr10_+_51549498 | 1.16 |
ENST00000358559.2
ENST00000298239.6 |
MSMB
|
microseminoprotein, beta- |
| chr18_-_31802282 | 1.16 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
| chr5_+_140174429 | 1.16 |
ENST00000520672.2
ENST00000378132.1 ENST00000526136.1 |
PCDHA2
|
protocadherin alpha 2 |
| chr13_+_78315466 | 1.16 |
ENST00000314070.5
ENST00000462234.1 |
SLAIN1
|
SLAIN motif family, member 1 |
| chr13_+_76334498 | 1.15 |
ENST00000534657.1
|
LMO7
|
LIM domain 7 |
| chr10_-_69425399 | 1.15 |
ENST00000330298.6
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3 |
| chr12_-_120189900 | 1.13 |
ENST00000546026.1
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
| chr2_-_241080069 | 1.12 |
ENST00000319460.1
|
OTOS
|
otospiralin |
| chr10_-_104597286 | 1.12 |
ENST00000369887.3
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1 |
| chr7_+_5465382 | 1.12 |
ENST00000609130.1
|
RP11-1275H24.2
|
RP11-1275H24.2 |
| chr1_+_50571949 | 1.11 |
ENST00000357083.4
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr1_+_156308403 | 1.10 |
ENST00000481479.1
ENST00000368252.1 ENST00000466306.1 ENST00000368251.1 |
TSACC
|
TSSK6 activating co-chaperone |
| chr6_-_137365402 | 1.10 |
ENST00000541547.1
|
IL20RA
|
interleukin 20 receptor, alpha |
| chr1_+_166958346 | 1.09 |
ENST00000367872.4
|
MAEL
|
maelstrom spermatogenic transposon silencer |
| chr19_+_58545369 | 1.09 |
ENST00000391700.1
|
ZSCAN1
|
zinc finger and SCAN domain containing 1 |
| chr4_-_87028478 | 1.08 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr3_-_112013071 | 1.08 |
ENST00000487372.1
ENST00000486574.1 ENST00000305815.5 |
SLC9C1
|
solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1 |
| chr3_+_107364683 | 1.07 |
ENST00000413213.1
|
BBX
|
bobby sox homolog (Drosophila) |
| chr10_-_62493223 | 1.07 |
ENST00000373827.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr6_+_132891461 | 1.06 |
ENST00000275198.1
|
TAAR6
|
trace amine associated receptor 6 |
| chr3_-_108672609 | 1.06 |
ENST00000393963.3
ENST00000471108.1 |
GUCA1C
|
guanylate cyclase activator 1C |
| chr5_+_140514782 | 1.06 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
| chr6_-_88001706 | 1.06 |
ENST00000369576.2
|
GJB7
|
gap junction protein, beta 7, 25kDa |
| chr8_-_79470728 | 1.06 |
ENST00000522807.1
ENST00000519242.1 ENST00000522302.1 |
RP11-594N15.2
|
RP11-594N15.2 |
| chrX_-_15683147 | 1.02 |
ENST00000380342.3
|
TMEM27
|
transmembrane protein 27 |
| chr19_+_58545434 | 1.02 |
ENST00000282326.1
ENST00000601162.1 |
ZSCAN1
|
zinc finger and SCAN domain containing 1 |
| chr3_-_178865747 | 1.02 |
ENST00000435560.1
|
RP11-360P21.2
|
RP11-360P21.2 |
| chr9_+_130890612 | 1.01 |
ENST00000443493.1
|
AL590708.2
|
AL590708.2 |
| chr4_-_87278857 | 1.00 |
ENST00000509464.1
ENST00000511167.1 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr2_-_183387064 | 1.00 |
ENST00000536095.1
ENST00000331935.6 ENST00000358139.2 ENST00000456212.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
| chr6_+_123317116 | 1.00 |
ENST00000275162.5
|
CLVS2
|
clavesin 2 |
| chr2_-_113542063 | 0.99 |
ENST00000263339.3
|
IL1A
|
interleukin 1, alpha |
| chr2_+_210444298 | 0.97 |
ENST00000445941.1
|
MAP2
|
microtubule-associated protein 2 |
| chr9_-_95166976 | 0.96 |
ENST00000447356.1
|
OGN
|
osteoglycin |
| chr4_-_150736962 | 0.95 |
ENST00000502345.1
ENST00000510975.1 ENST00000511993.1 |
RP11-526A4.1
|
RP11-526A4.1 |
| chr2_+_166430619 | 0.95 |
ENST00000409420.1
|
CSRNP3
|
cysteine-serine-rich nuclear protein 3 |
| chr6_-_154568551 | 0.95 |
ENST00000519190.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
| chr6_-_154567984 | 0.95 |
ENST00000517438.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
| chr2_+_166326157 | 0.94 |
ENST00000421875.1
ENST00000314499.7 ENST00000409664.1 |
CSRNP3
|
cysteine-serine-rich nuclear protein 3 |
| chr21_-_46424517 | 0.94 |
ENST00000422199.1
|
LINC00162
|
long intergenic non-protein coding RNA 162 |
| chr7_-_107443652 | 0.94 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
| chr6_-_50016364 | 0.93 |
ENST00000322246.4
|
DEFB112
|
defensin, beta 112 |
| chr18_-_11148587 | 0.93 |
ENST00000302079.6
ENST00000580640.1 ENST00000503781.3 |
PIEZO2
|
piezo-type mechanosensitive ion channel component 2 |
| chr3_-_169587621 | 0.92 |
ENST00000523069.1
ENST00000316428.5 ENST00000264676.5 |
LRRC31
|
leucine rich repeat containing 31 |
| chr12_+_52056548 | 0.92 |
ENST00000545061.1
ENST00000355133.3 |
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
| chr19_+_52839490 | 0.92 |
ENST00000321287.8
|
ZNF610
|
zinc finger protein 610 |
| chr12_+_12223867 | 0.92 |
ENST00000308721.5
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator) |
| chr20_-_9819674 | 0.91 |
ENST00000378429.3
|
PAK7
|
p21 protein (Cdc42/Rac)-activated kinase 7 |
| chr3_+_108308845 | 0.91 |
ENST00000479138.1
|
DZIP3
|
DAZ interacting zinc finger protein 3 |
| chr11_+_73661364 | 0.91 |
ENST00000339764.1
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
| chr11_-_84028339 | 0.90 |
ENST00000398301.2
|
DLG2
|
discs, large homolog 2 (Drosophila) |
| chr9_+_105757590 | 0.90 |
ENST00000374798.3
ENST00000487798.1 |
CYLC2
|
cylicin, basic protein of sperm head cytoskeleton 2 |
| chr6_-_52705641 | 0.90 |
ENST00000370989.2
|
GSTA5
|
glutathione S-transferase alpha 5 |
| chr14_+_62585332 | 0.89 |
ENST00000554895.1
|
LINC00643
|
long intergenic non-protein coding RNA 643 |
| chr17_-_73775839 | 0.89 |
ENST00000592643.1
ENST00000591890.1 ENST00000587171.1 ENST00000254810.4 ENST00000589599.1 |
H3F3B
|
H3 histone, family 3B (H3.3B) |
| chr1_+_156338993 | 0.89 |
ENST00000368249.1
ENST00000368246.2 ENST00000537040.1 ENST00000400992.2 ENST00000255013.3 ENST00000451864.2 |
RHBG
|
Rh family, B glycoprotein (gene/pseudogene) |
| chr10_+_90354503 | 0.88 |
ENST00000531458.1
|
LIPJ
|
lipase, family member J |
| chr11_-_111944704 | 0.88 |
ENST00000532211.1
|
PIH1D2
|
PIH1 domain containing 2 |
| chr12_+_100897130 | 0.88 |
ENST00000551379.1
ENST00000188403.7 ENST00000551184.1 |
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr13_+_76378305 | 0.87 |
ENST00000526371.1
ENST00000526528.1 |
LMO7
|
LIM domain 7 |
| chr4_-_87281224 | 0.87 |
ENST00000395169.3
ENST00000395161.2 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr15_+_36338242 | 0.87 |
ENST00000560056.1
|
RP11-684B21.1
|
RP11-684B21.1 |
| chr3_+_107364769 | 0.87 |
ENST00000449271.1
ENST00000425868.1 ENST00000449213.1 |
BBX
|
bobby sox homolog (Drosophila) |
| chr6_+_12718497 | 0.87 |
ENST00000379348.2
|
PHACTR1
|
phosphatase and actin regulator 1 |
| chr2_-_233641265 | 0.86 |
ENST00000438786.1
ENST00000409779.1 ENST00000233826.3 |
KCNJ13
|
potassium inwardly-rectifying channel, subfamily J, member 13 |
| chr15_+_45028719 | 0.85 |
ENST00000560442.1
ENST00000558329.1 ENST00000561043.1 |
TRIM69
|
tripartite motif containing 69 |
| chr15_+_65822756 | 0.85 |
ENST00000562901.1
ENST00000261875.5 ENST00000442729.2 ENST00000565299.1 ENST00000568793.1 |
PTPLAD1
|
protein tyrosine phosphatase-like A domain containing 1 |
| chr5_-_177207634 | 0.85 |
ENST00000513554.1
ENST00000440605.3 |
FAM153A
|
family with sequence similarity 153, member A |
| chr5_+_167181917 | 0.84 |
ENST00000519204.1
|
TENM2
|
teneurin transmembrane protein 2 |
| chr11_-_40315640 | 0.84 |
ENST00000278198.2
|
LRRC4C
|
leucine rich repeat containing 4C |
| chr9_-_74675521 | 0.83 |
ENST00000377024.3
|
C9orf57
|
chromosome 9 open reading frame 57 |
Network of associatons between targets according to the STRING database.
First level regulatory network of CDC5L
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.7 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.9 | 2.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.6 | 1.9 | GO:0018969 | thiocyanate metabolic process(GO:0018969) |
| 0.6 | 3.6 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.6 | 1.7 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
| 0.5 | 1.6 | GO:0048627 | myoblast development(GO:0048627) |
| 0.5 | 4.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.4 | 1.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.4 | 1.5 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 | 2.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.4 | 3.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 5.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.3 | 1.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.3 | 1.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 | 1.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.2 | 3.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 1.3 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.2 | 0.6 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 0.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.2 | 0.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.2 | 0.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 | 0.5 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 | 1.1 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 | 0.7 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.2 | 0.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.2 | 2.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.2 | 0.7 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 0.8 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.2 | 2.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 | 2.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.6 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.1 | 0.7 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 | 0.4 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.1 | 0.5 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 | 2.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 1.2 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 2.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 2.7 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 | 0.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 1.0 | GO:0035234 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 | 0.8 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 2.2 | GO:0006527 | arginine catabolic process(GO:0006527) negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 | 2.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 1.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 1.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 2.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 1.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.1 | 2.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.3 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.1 | 1.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 0.1 | 2.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 1.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.3 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.1 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 4.4 | GO:0046710 | GDP metabolic process(GO:0046710) receptor localization to synapse(GO:0097120) |
| 0.1 | 0.6 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 0.9 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.2 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 1.9 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 1.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.1 | 2.8 | GO:0006833 | water transport(GO:0006833) |
| 0.1 | 0.3 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.1 | 1.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 4.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.1 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 2.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 0.7 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.1 | 1.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.4 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.1 | 0.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 1.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.2 | GO:0042245 | RNA repair(GO:0042245) |
| 0.1 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 1.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 1.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.8 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 | 2.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.0 | 4.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 1.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 | 1.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 1.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 4.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 1.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.0 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 1.5 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 1.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 1.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.0 | 1.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 2.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 | 0.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.0 | 1.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 1.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 0.4 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 1.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.0 | 3.8 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 1.0 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 1.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
| 0.0 | 0.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 1.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 | 0.9 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
| 0.0 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
| 0.0 | 0.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.2 | GO:1901731 | protein secretion by platelet(GO:0070560) positive regulation of platelet aggregation(GO:1901731) |
| 0.0 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.1 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.0 | 0.1 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.0 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
| 0.0 | 2.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.6 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.0 | 2.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 | 1.1 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 1.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.0 | 8.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.0 | 2.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.1 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 | 3.8 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.0 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 | 0.4 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.0 | 0.3 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 | 2.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 2.7 | GO:0007605 | sensory perception of sound(GO:0007605) |
| 0.0 | 1.4 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
| 0.0 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.0 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 0.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 1.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 1.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.0 | 0.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.0 | 0.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
| 0.0 | 2.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 4.8 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.4 | 4.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 3.6 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.3 | 1.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.3 | 0.9 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.3 | 3.7 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.3 | 1.1 | GO:0030849 | autosome(GO:0030849) |
| 0.3 | 0.8 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.3 | 1.6 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.2 | 5.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 2.5 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.2 | 2.6 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 3.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 0.4 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.1 | 3.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 0.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.3 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 0.1 | 0.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 2.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 3.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 4.5 | GO:0030286 | dynein complex(GO:0030286) |
| 0.0 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.0 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 1.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.0 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 1.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 0.2 | GO:0031673 | H zone(GO:0031673) |
| 0.0 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.0 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 2.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 1.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.0 | 10.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.0 | 0.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 2.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 9.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 2.3 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.8 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 1.2 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 0.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.6 | 1.9 | GO:0036393 | thiocyanate peroxidase activity(GO:0036393) |
| 0.6 | 1.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.6 | 2.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.5 | 5.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.4 | 1.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.3 | 2.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.3 | 9.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 3.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 0.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.2 | 0.9 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.2 | 1.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.2 | 1.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.2 | 1.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 0.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 2.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.2 | 4.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.2 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 1.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.2 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.2 | 2.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.2 | 1.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 5.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 2.8 | GO:0015250 | water channel activity(GO:0015250) |
| 0.2 | 1.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.6 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 1.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 3.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 0.6 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.1 | 1.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 2.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 1.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 3.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 3.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 2.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 3.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 1.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 2.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 0.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 1.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 2.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 1.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 2.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 4.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 0.5 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 1.1 | GO:0022821 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.1 | 1.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 2.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.1 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 0.5 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 1.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.4 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 1.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 2.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 2.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 2.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 1.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.0 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.0 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 0.9 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.0 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.0 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 1.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.0 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.0 | 3.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.0 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.0 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.3 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.0 | 0.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.0 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.1 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.0 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.0 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 3.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 1.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 1.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
| 0.0 | 2.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 2.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 6.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 2.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 5.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 2.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 4.5 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 1.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 2.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.0 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.0 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.0 | 5.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 1.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 2.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 4.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 6.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 2.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 6.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 2.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 1.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 2.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 3.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 4.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 1.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 2.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 2.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 1.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 2.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 1.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 1.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 0.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 1.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 1.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.0 | 3.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 3.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |